结论0.25%和0.375%罗哌卡因溶液用于臂丛阻滞效果完善且安全可靠，不必加肾上腺素。
Conclusion The ropivacaine in 0.25% and 0.375% might have perfect blockage effect that should not add the adrenaline.
目的：探讨泰素加卡铂联合化疗方案对非小细胞肺癌的疗效。
Objective:To investigate the efficacy of treating taxol plus carboplatin in the treatment of non-small cell lung cancer.
目的观察比较泰素加卡铂与泰素加顺铂治疗晚期肺腺癌的近期疗效及不良反应。
Objective To evaluate and compare the efficacy and toxicity of taxol plus carboplatin and tax-ol plus cisplatin on the treatment of advanced pulmonary adenocarcinoma.
方法对33例应用泰素加卡铂治疗的晚期非小细胞肺癌患者进行分析。
Methods Analysis of 33 cases of NSCLC treated by Taxol and Carboplatin.
结论：泰素加卡铂联合化疗方案对中晚期非小细胞肺癌有较好疗效，不良反应小。
Conclusion: the efficacy of treating intermediate and late non-small cell lung cancer with combined taxol and carboplatin chemotherapy is fairly good. The adverse reactions are mild and tolerable.
观察利多卡因加肾上腺素对安置永久性人工心脏起搏器患者皮下囊袋血肿及安全性方面的影响。
To study the effect of lidocaine combined with epinephrine on pocket hematoma after implantation of permanent cardiac pacemaker and its safety.
观察利多卡因加肾上腺素对安置永久性人工心脏起搏器患者皮下囊袋血肿及安全性方面的影响。
To study the effect of lidocaine combined with epinephrine on pocket hematoma after implantation of permanent cardiac pacemaker and its safety.
应用推荐